IVCC and Avient joined forces to step up the global fight to eradicate malaria. IVCC’s strategy to deliver effective control of malaria-transmitting mosquitoes focuses on discovering new insecticides for protecting against malaria. Avient and IVCC created a new medium scale masterbatch production laboratory in China to support research and development into non-registered novel active ingredients for incorporation into long lasting treated nets.

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Schuering Page 77 Appliance 5% Building & Construction 3% Wire & Cable Electrical & Electronics Consumer 21% Industrial 24% HealthCare 21% Transportation 17% 2011 Revenue: $1.0 Billion2011 Revenue: $1.0 Billion Key SuppliersKey Suppliers At a Glance Packaging 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales ROICROIC Expanding ProfitsExpanding Profits 15.3% 18.4% 22.4% 30.0% 39.2% 48.6% 2006 2007 2008 2009 2010 2011 Target 6 – 7.5% Page 78 Value Proposition and Transformation Highlights Value Proposition • North America-based distributor with expanding global reach providing key plastic processors and market segments with best-in-class suppliers products, service and delivery with a commitment to develop value-added solutions to enhance customer profitability Transformation Highlights • Significant market share gains with key suppliers , > $5B Addressable Market • Significant market share gains with key suppliers � Proprietary PolyOne technology � Dow Corning • Improved sales mix and profitability by shifting to non-cyclical businesses like healthcare • Established presence in Brazil and Asia in 2011 Page 79 Key Differentiators • Product offering � Breadth and depth; industry leading suppliers • Sales and marketing capability • Customer service / logistics operations � Customer survey results – consistent best-in-class performance � Leading on-time delivery • Management team experience and stability • Lean Six Sigma � Solving our customers’ unmet needs Page 80 $102.8 $207.2 Healthcare Revenue • Strong market segmentation provides focused resourcing to accelerate growth • Expanding global reach meets Areas of Focus $66.0 $182.4 National Accounts Revenue • Expanding global reach meets customers’ needs and creates competitive differentiation • Selling skills & product application knowledge to target executives & engineers ($ millions) Page 81 Critical Imperatives • Invest in commercial resources to accelerate growth • Expand healthcare and key account revenues • Broaden geographic reach and develop new markets and channel partnerships Critical Imperatives and 2015 Goal channel partnerships • Continue to improve working capital efficiency and superior cash flow generation 2015 Goal • 6 - 7.5% return on sales Page 82 Page 83

Edison, New Jersey 4. Newark, New Jersey 10. Lockport, New York 12.

With the sale of DSS, we can now entirely focus on accelerating growth in our four core segments. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. SEARCH INVESTOR NEWS